Imcas 2025: New Galderma Category IIBIB Data Strengthening Quick Review and Development Long-Last Reformation (Relfydess ™ ™)

Content of article

• Begins the results from the phase of the phase of the Real Real Clinical Grovel Grovel Grovel Dating The higher and continuous treatment of the Renalitulinumtulini (Relfydess^H) A balanced sense to powerful lines (glabellar lines) beyond six months
• These results strengthen the effect of the Clinical Clinical for 6 months and speeding from 1 day shown in the III III’s trial program^1,2
• Data also indicated the highest patient satisfaction of the processes of treatment and more than six months¹
• Developed and produced by galderma, revotulinumtuloxina by the first liquid and ready for use used using Pearl^H Technology used for a simple volumetric to grow easily use^3,4,5

Content of article

Content of article

Content of article

ZUG, Switzerland – Galdema (SWX: GLDDERA), clean paragraphs leader and increasing self-esteem, using a single frequent dose of the frown (Glabellar lines)¹. Galdama’s analysis was exposed to the Aging Master course in Aging Science (Imcas) 2025 Annual Summit, held in Paris on January 30 to February 1, 2025.

Developed and produced by galderma, Renabatulinumtulinumino is the first neuromodulator and ready for a spoken technique designed to keep molecule’s most effective, new, hard comfortable molecule^3,4,5. Data was announced from III phase test displayed prompt establishment as soon as 1 day to treat frown lines and concrete feet (recent canthal) ^2,6.

Relax is a section IIB, MultiCenter, Military, Blind, Twice Control Court, Planter-Completed Court Discovered to evaluate RealBotulinumtulinumtulinMotulini in the 132 adults in 12 months^1,7.

• The results sponsored quick inventory for the development of the beauty on the day 1 (40%; reported-reported) and six months’ work period¹.
• Pre-considerment and treatment of divine appearance and higher, which is 92% of the content of the treatment of the month in Mount 1, is satisfied with 60% in 6 month,¹.
• In addition, in a month of 6 and in 12 month, over 50% reported to raise their confidence and look good in their age, highlighting the strong benefulinalo density.¹.
• The investigators reported the highest maximum of ≥1 basis prices. Relenatulinumtulinina continues to be tolerated well without side-related bad events¹.

Content of article

Content of article

After successful completing the effective European Decentral process, resulting in the use of the Relfydess (Exercererma.

More information about Gallerman scientific introductions in Imcas can be found here.

About Renabutulinumtoxina
A pioneer is a galderma, RealBotulinumtulinimotina is the first neuromodolor and ready for the use of the only person made of Pearl technology designed to maintain the integrity of molecule^4,5. Pearl technology designed to bring a very active, complex, complex, up to 39% of patients seeing results from 75% of patients who maintain six-month improvement.^3,4,5,6. The Renabutulinumtuloxino is designed for easy simple Vosing, without recycling, increasing use and helping ensure the dose / unchanging capacity at all times^4,5. It was fully developed and produced by galderma to increase its neuromodator portfolio as part of a broad-market portfolio.

About galderma
Galdererma (six: GALD) is a cleaner Dermatology, available in nearly 90 countries. We bring a new portfolio, based on Premium Flagships and full-time Dermatology Market services for the IFTETTISS, Dermatological SkanCare and Treater Dermatology. Since our foundation in 1981, we have offered our focus on the great orientation of a human body – the skin – we meet each consumer and patient needs through high-quality health care results. Because we understand that the skin we are in mingol is our lives, we continue dermatology throughout the skin of the skin. For more information: www.galdererma.com.

Content of article

References:

¹ Protherh HB, et al. The effective and safety of botulinum is the botulinum toxin, the RealBotulinumtuloxina, where is used for combined glabellar and recycles. IE-POSTO is presented to: ASD 2024; October 17-20, 2024; Orlando, FL
² Ibrahim SF, et al. Renalont – Glabellar lines and latest canthal lines throughout race and distinctive ethnicity: Data installed in three sections from three phase III studies. IE-POSTO is presented to: ASD 2024; October 17-20, 2024; Orlando, FL
⁺ The Sundberg al and Stahl u. Renabatulinum toxin – the novel, higher Bont-A1 purest in liquid use. Presented to: toxic 2021; Jan 16-17, 2021; Dear Convention
⁴ Make M, et al. Botulinum neurotoxin cleansing process of botulinum neurotoxin A1 (Bont-A1) – Renalittulinumtulinina. Presented to: toxic 2022; July 27-30, 2022; New Orleans, La
^{The knee was purchased} Persson C, et al. The patient’s treatment experience and investigate Abobotulinumtulinumto Solution Versus powder botulinumto. Abstracts presented in Toxins 2024; Jan 17-20, 2024, Berlin
⁶ Based on the search of the May 2023 across the PUBMED, at the clinic.gov, and Eudract
^{And the bought the lurch +} Galderma. Data in file. PROT111 study study report: Relax. Galdema Laboratories

View source version at Busienesswire.com: https://www.susinesswire.com/news/home/20250130978800/en/

Contacts

For more information:

Christian Marcoux, M.SC.
A large official to communicate
Christian.marcoux@galderma.com
+41 71165

Sébastien Cros
Director of Communications
sebastien.cros@galderma.com
+41 79 529 59 85 85

Emil Ivanov
Head of Strategies, Money relationships, and ESG
Emil.ivanov@galderma.com
+41 21 642 78 12

Jessica Cohen
Money relationships and Director of Treasures
jessica.cohen@galderma.com
+41 21 642 76 43

#ditro

Content of article